The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.
24 May 2013
Based on his recent research, Prof Henry Grabowski of Duke University will discuss the factors most likely to determine market penetration by biosimilars.
19 May 2013
Prof Alan Maynard will explore the roles of incentives and regulation in NHS contracts, set against the background of the Francis Report.
15 May 2013
This study interviewed decision makers in eight countries to identify barriers to a broader perspective.
13 May 2013
Prof Towse describes three critical challenges that face ISPOR in the near term.
06 May 2013
A new OHE publication reports on a study that tests the use of MCDA for orphan drugs.
05 May 2013
OHE’s Policy Board provides advice and guidance to the OHE on its research programmes.